Sign In
NewsRadar

Crescendo Biologics

Crescendo Biologics will apply antibody fragment technologies to the development of new targeted therapeutics. The Crescendo transgenic mouse platform under development has the potential to generate high-affinity human heavy chain antibodies that yield human heavy chain (VH) fragments that have no requirement for humanization. This is combined with in vitro ribosome display technology for antibody optimization.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Web:
Contact:
 
 
Meditrina Building 260
Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
+44 (0) 1223 497140
http://www.crescendobiologics.com
Mike Romanos
+44(0)1223-497140

Company Facts
Founded:
Founders:
CEO:Mike Romanos
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


27,633
Tech investments
From our Online Data Service
17,827
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology
Dec 3€21.0MBusiness applications
Dec 2€7.0MDigital signal processing
Dec 2€7.4MBiotechnology
Nov 30€3.7MConsumer electronics
Nov 12€20.0MAgriculture related

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.